GSK3B and breast carcinoma: The overall results of this study showed that a fascinating protocol for the production of new anticancer agents targeting the GSK3β enzyme for the treatment of breast cancer was the molecular hybridization of 1,2,3-triazole to biologically interesting imidazole scaffolds with diverse aromatic substituents.